BONVINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.892
AS - Asia 1.214
EU - Europa 602
AF - Africa 189
SA - Sud America 184
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 4.111
Nazione #
US - Stati Uniti d'America 1.777
SG - Singapore 383
CN - Cina 240
VN - Vietnam 212
BR - Brasile 121
IT - Italia 107
HK - Hong Kong 95
DE - Germania 90
FI - Finlandia 57
IN - India 49
FR - Francia 44
CA - Canada 36
NL - Olanda 34
PL - Polonia 32
GB - Regno Unito 31
SE - Svezia 28
BD - Bangladesh 27
ES - Italia 27
RU - Federazione Russa 20
AR - Argentina 18
JP - Giappone 17
AT - Austria 16
PH - Filippine 16
ZA - Sudafrica 15
SA - Arabia Saudita 14
IQ - Iraq 13
KR - Corea 13
MX - Messico 13
TR - Turchia 13
DZ - Algeria 12
UA - Ucraina 11
CI - Costa d'Avorio 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
EC - Ecuador 9
AO - Angola 8
BZ - Belize 8
TN - Tunisia 8
VE - Venezuela 8
AU - Australia 7
BJ - Benin 7
CL - Cile 7
CO - Colombia 7
HN - Honduras 7
ID - Indonesia 7
IL - Israele 7
LV - Lettonia 7
MU - Mauritius 7
MY - Malesia 7
NC - Nuova Caledonia 7
UZ - Uzbekistan 7
YE - Yemen 7
CU - Cuba 6
CW - ???statistics.table.value.countryCode.CW??? 6
GP - Guadalupe 6
JO - Giordania 6
MK - Macedonia 6
MR - Mauritania 6
MW - Malawi 6
PA - Panama 6
TJ - Tagikistan 6
BW - Botswana 5
BY - Bielorussia 5
CH - Svizzera 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
GA - Gabon 5
GE - Georgia 5
GH - Ghana 5
GN - Guinea 5
GR - Grecia 5
KE - Kenya 5
LY - Libia 5
ME - Montenegro 5
MG - Madagascar 5
ML - Mali 5
MN - Mongolia 5
PS - Palestinian Territory 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BE - Belgio 4
CG - Congo 4
CV - Capo Verde 4
GF - Guiana Francese 4
HR - Croazia 4
IE - Irlanda 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
MA - Marocco 4
MD - Moldavia 4
NA - Namibia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
Totale 3.973
Città #
Ashburn 278
Singapore 232
San Jose 198
Fairfield 141
Chandler 131
Woodbridge 93
Hong Kong 85
Ann Arbor 61
Hanoi 59
Cambridge 57
Houston 55
Beijing 51
Ho Chi Minh City 49
Wilmington 47
Seattle 45
Munich 41
Los Angeles 38
Santa Clara 38
Helsinki 33
New York 32
Padova 31
Council Bluffs 23
San Diego 21
Boardman 20
Da Nang 19
Lauterbourg 18
Princeton 18
Nuremberg 17
The Dalles 17
Dallas 16
São Paulo 16
Medford 15
Milan 15
Warsaw 15
Buffalo 14
Turku 14
Bytom 13
Chennai 13
Des Moines 13
Tokyo 13
Jacksonville 11
Montreal 11
Abidjan 10
Dong Ket 10
Johannesburg 10
Atlanta 9
Toronto 9
Amsterdam 7
Boston 7
Chicago 7
Denver 7
Frankfurt am Main 7
Hefei 7
Jeddah 7
London 7
Noumea 7
Riyadh 7
Seoul 7
Vienna 7
Amman 6
Biên Hòa 6
Brooklyn 6
Cotonou 6
Guangzhou 6
Haiphong 6
Luanda 6
Mumbai 6
Nouakchott 6
Phoenix 6
Stockholm 6
Tashkent 6
Washington 6
Accra 5
Antananarivo 5
Baghdad 5
Bamako 5
Bologna 5
Changsha 5
Conakry 5
Dushanbe 5
Havana 5
Istanbul 5
Jinan 5
Lappeenranta 5
Nanchang 5
North York 5
Orem 5
Podgorica 5
Poplar 5
Riga 5
Rio de Janeiro 5
Sanaa 5
Tbilisi 5
Thái Nguyên 5
Turin 5
Addis Ababa 4
Algiers 4
Baku 4
Belgrade 4
Belize City 4
Totale 2.472
Nome #
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 327
3D extracellular matrix derived model of alveolar rhabdomyosarcoma 283
Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study 262
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. 261
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma 256
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma 254
Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor 250
Liquid biopsy in pediatric renal cancer: Stage I and stage IV cases compared 239
Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma 238
Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma 233
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors. 219
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner 218
Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance 209
Understanding the interplay between expression, mutation and activity of ALK receptor in Rhabdomyosarcoma cells for clinical application of small-molecule inhibitors 204
A 3D model for the study of the role of glypican 3 in rhabdomyosarcoma progression 194
Impatto clinico della soppressione di SIK1 da parte di miR-223 in pazienti pediatrici affetti da linfoma linfoblastico T 187
Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness 171
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study 132
Totale 4.137
Categoria #
all - tutte 12.211
article - articoli 11.062
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 13 31
2021/2022242 3 22 26 16 6 16 20 28 12 18 24 51
2022/2023255 36 28 11 50 22 30 2 19 37 5 13 2
2023/2024199 12 24 24 15 30 42 17 6 1 3 18 7
2024/2025633 9 39 38 15 57 35 22 58 53 14 110 183
2025/20262.289 139 137 233 411 192 111 401 178 251 126 110 0
Totale 4.137